021-51111890
购物车（）
sales@molnova.cn
GLP-1(7-37) acetate(106612-94-6 free base)
CAS No. 1450806-98-0
GLP-1(7-37) acetate(106612-94-6 free base) ( —— )
产品货号. M23617 CAS No. 1450806-98-0
Glp-1 (7-37) acetate is an intestinal insulin hormone that enhances glucose-induced insulin secretion.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ￥1847 | 有现货 |
|
| 10MG | ￥2811 | 有现货 |
|
| 25MG | ￥4771 | 有现货 |
|
| 50MG | ￥6820 | 有现货 |
|
| 100MG | ￥9396 | 有现货 |
|
| 200MG | 获取报价 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称GLP-1(7-37) acetate(106612-94-6 free base)
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述Glp-1 (7-37) acetate is an intestinal insulin hormone that enhances glucose-induced insulin secretion.
-
产品描述Glp-1 (7-37) acetate is an intestinal insulin hormone that enhances glucose-induced insulin secretion.
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体Others
-
研究领域——
-
适应症——
化学信息
-
CAS Number1450806-98-0
-
分子量3355.7
-
分子式C151H228N40O47
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESO=C(N[C@@H](C)C(N[C@@H](CCC(O)=O)C(NCC(N[C@@H]([C@H](O)C)C(N[C@@H](CC1=CC=CC=C1)C(N[C@@H]([C@H](O)C)C(N[C@@H](CO)C(N[C@@H](CC(O)=O)C(N[C@@H](C(C)C)C(N[C@@H](CO)C(N[C@@H](CO)C(N[C@@H](CC2=CC=C(C=C2)O)C(N[C@@H](CC(C)C)C(N[C@@H](CCC(O)=O)C(NCC(N[C@@H](CCC(N)=O)C(N[C@@H](C)C(N[C@@H](C)C(N[C@@H](CCCCN)C(N[C@@H](CCC(O)=O)C(N[C@@H](CC3=CC=CC=C3)C(N[C@@H]([C@@H](C)CC)C(N[C@@H](C)C(N[C@@H](CC4=CNC5=CC=CC=C45)C(N[C@@H](CC(C)C)C(N[C@@H](C(C)C)C(N[C@@H](CCCCN)C(NCC(N[C@@H](CCCNC(N)=N)C(NCC(O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)[C@H](CC6=CNC=N6)N
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Sarrauste de Menthiere, C. et al. Structural requirements of the N-terminal region of GLP-1-[7-37]-NH2 for receptor interaction and cAMP production. European journal of medicinal chemistry 39, 473-480, doi:10.1016/j.ejmech.2004.02.002 (2004).
产品手册
关联产品
-
2-Ethylbutyric Acid
2-Ethylbutyric Acid is a natural compound.
-
Decuroside I
Decuroside I shows weak inhibiting activity against the primary and secondary wave aggregation of human platelet.
-
T3Inh-1
T3Inh-1 is an effective and selective inhibitor of ppGalNAc-T3 with an IC50 of 7 μM. T3Inh-1 prevents breast cancer cells. T3Inh-1 reduces FGF23 hormone levels in both tissue cells and mice, without causing any toxic side effects.
